Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autologous bone marrow transplantation

R J Jones1

  • 1Johns Hopkins Oncology Center, Baltimore, Maryland.

Current Opinion in Oncology
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

High-dose chemotherapy with bone marrow transplantation is key for hematologic cancers. Autologous bone marrow transplantation shows promise for solid tumors but requires further research to confirm survival benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems data.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Cancer Trial Impact: Understanding Implementation of the Short Course Oncology Treatment (SCOT) Trial Findings in colorectal cancer at a National Level.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

Using diffusion MRI data acquired with ultra-high gradient strength to improve tractography in routine-quality data.

NeuroImage·2021
Same author

Fermentative volatile fatty acid production and recovery from grass using a novel combination of solids separation, pervaporation, and electrodialysis technologies.

Bioresource technology·2021
Same author

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • High-dose cytotoxic therapy with bone marrow transplantation is a primary treatment for hematologic malignancies, especially at relapse.
  • Autologous bone marrow transplantation (ABMT) and allogeneic bone marrow transplantation (Allo-BMT) offer comparable outcomes in lymphoma and acute leukemia.
  • ABMT provides greater availability and lower toxicity but carries a higher risk of tumor recurrence compared to Allo-BMT.

Purpose of the Study:

  • To review the efficacy and role of bone marrow transplantation, particularly ABMT, in treating hematologic malignancies and solid tumors.
  • To explore novel strategies for enhancing the antitumor activity of ABMT without increasing toxicity.
  • To evaluate the established role of ABMT in solid tumor treatment and identify areas for future investigation.

Related Experiment Videos

Main Methods:

  • Review of current treatment paradigms for hematologic malignancies and solid tumors utilizing bone marrow transplantation.
  • Analysis of comparative outcomes between autologous and allogeneic bone marrow transplantation in specific cancer types.
  • Examination of ongoing research into dose intensification and novel approaches for ABMT.

Main Results:

  • ABMT and Allo-BMT yield similar results in lymphoma and acute leukemia, with ABMT offering practical advantages but a higher recurrence rate.
  • Dose intensification with ABMT is active against responsive solid tumors like breast, ovarian, and testicular cancers, as well as pediatric solid tumors.
  • Demonstrating improved disease-free survival with ABMT in solid tumors remains challenging.

Conclusions:

  • ABMT is a valuable treatment for hematologic malignancies, with ongoing research focused on improving its efficacy and safety profile.
  • The role of ABMT in the curative treatment of solid tumors is still under investigation and requires further evidence to establish its definitive place in therapy.
  • Future research should prioritize strategies to enhance ABMT's antitumor effects in solid tumors while mitigating recurrence risks.